Patent ID: 8853236
Filing Date: 2014-10-07
Classification: A61K,A61P,B82Y

Abstract:
1. A method of treating or preventing a disease, disorder or condition that is therapeutically responsive to clopidogrel in a patient in need thereof, wherein the disease, disorder or condition is selected from the group consisting of myocardial infarction, stroke, vascular death, peripheral arterial disease (PAD), secondary ischemic events, acute coronary syndrome, transient ischemic attack, cerebrovascular disease, cardiovascular disease, angina pectoris, deep vein thrombosis (DVT), pulmonary emboli (PE), sickle cell crisis, and cardiac arrhythmia, comprising administering intravenously to the patient a composition comprising a therapeutically effective amount of the clopidogrel and further comprising a sulfoalkyl ether cyclodextrin (SAE-CD) of Formula 1: wherein: n is 4, 5, or 6; R